Login / Signup

Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer.

Unurjargal BayasgalanSung Ho MoonJong Hwi JeongTae Hyun KimKwan Ho ChoYang Gun Suh
Published in: Radiation oncology (London, England) (2021)
Passive scattering proton beam therapy for stage I NSCLC using SABR or hypofractionated RT was safe and showed high LC rates.
Keyphrases
  • monte carlo
  • small cell lung cancer
  • radiation therapy
  • brain metastases
  • advanced non small cell lung cancer
  • electron microscopy
  • simultaneous determination
  • mass spectrometry
  • high resolution